Everyman’s prostate phantom: kiwi-fruit substitute for human prostates at magnetic resonance imaging, diffusion-weighted imaging and magnetic resonance spectroscopy

[1] De Visschere PJ(2016)Multiparametric magnetic resonance imaging characteristics of normal, benign and malignant conditions in the prostate Eur Radiol 22 746-757

[2] Vral A(2012)ESUR prostate MR guidelines 2012 Eur Radiol 185 253-261

[3] Perletti G(2013)PI-RADS classification: structured reporting for MRI of the prostate Fortschr Röntgenstr 32 45.e17-22

[4] Barentsz JO(2014)The accuracy of multiparametric MRI in men with negative biopsy and elevated PSA level—can it rule out clinically significant prostate cancer? Urol Oncol 164 400-404

[5] Richenberg J(2000)Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology J Urol 13 65-70

[6] Clements R(2010)Prostate cancer detection using an extended prostate biopsy schema in combination with additional targeted cores from suspicious images in conventional and functional endorectal magnetic resonance imaging of the prostate Prostate Cancer Prostatic Dis 16 1875-1883

[7] Roethke M(2010)Value of magnetic resonance spectroscopy imaging and dynamic contrast-enhanced imaging for detecting prostate cancer foci in men with prior negative biopsy Clin Cancer Res 55 575-590

[8] Blondin D(2009)Combined magnetic resonance imaging and magnetic resonance spectroscopy imaging in the diagnosis of prostate cancer: a systematic review and meta-analysis Eur Urol 67 627-636

[9] Schlemmer HP(2015)Magnetic resonance imaging in active surveillance of prostate cancer: a systematic review Eur Urol 69 16-40

[10] Franiel T(2016)PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2 Eur Urol 199 822-829

[1] De Visschere PJ(2016)Multiparametric magnetic resonance imaging characteristics of normal, benign and malignant conditions in the prostate Eur Radiol 22 746-757

[2] Vral A(2012)ESUR prostate MR guidelines 2012 Eur Radiol 185 253-261

[3] Perletti G(2013)PI-RADS classification: structured reporting for MRI of the prostate Fortschr Röntgenstr 32 45.e17-22

[4] Barentsz JO(2014)The accuracy of multiparametric MRI in men with negative biopsy and elevated PSA level—can it rule out clinically significant prostate cancer? Urol Oncol 164 400-404

[5] Richenberg J(2000)Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology J Urol 13 65-70

[6] Clements R(2010)Prostate cancer detection using an extended prostate biopsy schema in combination with additional targeted cores from suspicious images in conventional and functional endorectal magnetic resonance imaging of the prostate Prostate Cancer Prostatic Dis 16 1875-1883

[7] Roethke M(2010)Value of magnetic resonance spectroscopy imaging and dynamic contrast-enhanced imaging for detecting prostate cancer foci in men with prior negative biopsy Clin Cancer Res 55 575-590

[8] Blondin D(2009)Combined magnetic resonance imaging and magnetic resonance spectroscopy imaging in the diagnosis of prostate cancer: a systematic review and meta-analysis Eur Urol 67 627-636

[9] Schlemmer HP(2015)Magnetic resonance imaging in active surveillance of prostate cancer: a systematic review Eur Urol 69 16-40

[10] Franiel T(2016)PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2 Eur Urol 199 822-829